All posts by imreal

Abbott, Roche and Danaher Lead $54 Billion U.S. In Vitro Diagnostic (IVD) Market: Kalorama Information Report

[ad_1]

Molecular non-infectious disease diagnostics, POC diabetes and histology will contribute the most growth to the U.S. IVD market.

Abbott is the #1 vendor in the United States in vitro diagnostics (IVD) market, according to United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition, a recent report from medical market researcher Kalorama Information. Roche is second and Danaher (which includes Radiometer, Beckman Coulter and Cepheid) was third.

These leading companies compete in a $54 billion market, according to the report, the 4th edition of Kalorama’s dedicated analysis of the United States market. Kalorama publishes reports on the in vitro diagnostics markets and has been for over two decades.

The U.S. IVD market is highly developed and, in some segments, dominated by a handful of leading market players. In addition to molecular non-infectious disease diagnostics (+9.7%), POC diabetes (+5.9%) and histology (+4.3%) are expected to contribute the most growth to the U.S. IVD market.

Future U.S. IVD market growth will be a product of several factors including demographic aging; diminishing year-over-year gains on patient volumes and healthcare utilization; modest economic growth and stability in the U.S. market; and the introduction of new diagnostic technologies, particularly in the treatment of cancer and critical infections.

More information and specific market share percentages can be found in Kalorama Information’s report, In Vitro Diagnostic (IVD) Tests, 4th Edition, for sale at: https://kaloramainformation.com/product/united-states-market-for-in-vitro-diagnostic-ivd-tests-2022/

About Kalorama Information:

Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Kalorama Information produces 30 reports a year. The firm offers a Knowledge Center, which provides access to all published reports.

Share article on social media or email:

[ad_2]

Chapters Health System Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture and Meet Compliance Requirements

[ad_1]

News Image

“The achievement of a HITRUST Risk-based Two-year Certification provides reliable assurances that Chapters Health System is taking information risk management and compliance seriously,” said Vincent Bennekers, vice president of quality, HITRUST.

Chapters Health System, one of the nation’s premier not-for-profit, community-based healthcare organizations, today announced the Chapters Health CareCentrium Environment, hosted in the Flexential Data Center located in Tampa, FL, has earned certified status for information security by HITRUST.

HITRUST Risk-based 2-year certified status confirms Chapters Health’s hospice and home health affiliates meet key regulations and industry-defined requirements and appropriately manage risk. The achievement elevates Chapters Health into exclusive group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks, and incorporating a risk-based approach, the HITRUST Assurance Program helps organizations address security and data protections challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.

“Healthcare organizations have a duty to meet complex compliance, privacy, and risk management requirements that include technical and process elements contained in frameworks such as NIST and ISO,” said Mike Parkin, director, IT security CISO, Chapters Health System. “As a leader in our space, we are pleased to demonstrate to our patients, families and partners our dedication to the highest standards for data protection and information security by achieving the HITRUST Risk-based, 2-year Certification.”

“In today’s ever-changing threat landscape, HITRUST is continually innovating to find new and creative approaches to address challenges,” said Jeremy Huval, chief innovation officer, HITRUST. “Chapters Health System’s HITRUST Risk-based 2-year Certification is evidence that they are at the forefront of industry best practices for information risk management and compliance.”

About Chapters Health System

As a progressive leader and premier health system, Chapters Health System is dedicated to delivering innovative home health, palliative and hospice care along with durable medical equipment and pharmacy services. Since 1983 as a community-based, not-for-profit organization, Chapters Health has provided choices, education and guidance through its managed affiliates. All offerings are provided in order to improve the patient/family experience well in advance of end-of-life needs. In 2022, Chapters Health is certified for the fifth consecutive year as a great workplace in the Aging Services category by the independent analysts at the Great Place to Work® Institute and in 2021, Chapters Health was named a Top Workplace by the Tampa Bay Times. To learn more, visit http://www.chaptershealth.org, like us on Facebook or follow us on Twitter and LinkedIn.

Share article on social media or email:



[ad_2]

Mount Sinai Appoints Michal A. Elovitz, MD, as Dean for Women’s Health

[ad_1]

“I am excited to have this opportunity to mentor and sponsor the next generation of promising physician-scientists and scientists in women’s health at Mount Sinai.” -Michal A. Elovitz, MD

Michal A. Elovitz, MD, a renowned leader in maternal-fetal medicine and expert in preterm birth, has been named Dean for Women’s Health Research and Director of the Center for the Advancement of Female Biology at the Icahn School of Medicine at Mount Sinai. She will join the school on Wednesday, March 1, 2023.

In these new positions, Dr. Elovitz will advance research into women’s health and female biology across all major departments and institutes within Icahn Mount Sinai, which includes launching new multidisciplinary studies related to women’s health and sex-specific and female biology, and collaborating with The Blavatnik Family Women’s Health Research Institute, the Precision Immunology Institute (PrIISM), and the Black Family Stem Cell Institute.

“I am thrilled to join the Mount Sinai community and look forward to collaborating with exceptional scientists from diverse disciplines across the campus to create foundational programs to advance women’s health science and to make meaningful advances to improve health for women across their lifespan,” said Dr. Elovitz. “I am excited to have this opportunity to mentor and sponsor the next generation of promising physician-scientists and scientists in women’s health at Mount Sinai. I remain committed to promoting equity and empowering women as physicians, scientists, and leaders in medicine and science.”

Dr. Elovitz’s research has focused on understanding the underlying biological mechanisms and consequences of adverse reproductive and pregnancy outcomes and their implications for the long-term health of the mother and child. Her research integrating immunology and microbiology into pregnancy health has led to critical discoveries in predicting and understanding preterm birth. Dr. Elovitz’s research portfolio, which is funded by the National Institute of Child Health and Human Development, the National Institute of Nursing Research, and the National Institute of Allergy and Infectious Diseases, will continue at the Center for the Advancement of Female Biology at Mount Sinai.

“We are immensely proud to recruit one of the world’s leading physicians in women’s health, Michal A. Elovitz, now a trusted and valued colleague,” said Dennis Charney, MD, Anne and Joel Ehrenkranz Dean of Icahn Mount Sinai and President for Academic Affairs of the Mount Sinai Health System. “Dr. Elovitz will continue her more than 20 years of innovative bench-to-bedside research in maternal, reproductive, and child health at Mount Sinai, and with her expertise and knowledge, will lead the charge to seamlessly integrate female biology and women’s health across all facets of learning, scientific discovery, and health care throughout our Health System.”

Dr. Elovitz joins Mount Sinai from the Perelman School of Medicine at the University of Pennsylvania, where she has been the Hilarie L. Morgan and Mitchell L. Morgan President’s Distinguished Professor in Women’s Health and a Professor of Microbiology, as well as founder and Director of the Maternal and Child Health Research Center, Vice Chair for Translational Research, founder and Director of the Prematurity Prevention Program, Director of the Maternal Fetal Medicine Fellowship, and Creator and Lead Mentor of the Women for Women’s Health Mentoring Group.

Dr. Elovitz received her MD from Albert Einstein College of Medicine, and completed her residency in obstetrics and gynecology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and her fellowship in maternal-fetal medicine at the University of Chicago. She is a longtime active member of the National Institutes of Health peer review process and has served as a reviewer for more than 20 scientific journals; she has authored or co-authored more than 175 peer-reviewed publications. Dr. Elovitz is a member of the American College of Obstetrics & Gynecology, the Society of Maternal Fetal Medicine, and the Society of Reproductive Investigation.

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools,” aligned with a U.S. News & World Report “Honor Roll” Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York City and in the top five globally, and Mount Sinai Morningside in the top 30 globally; Newsweek also ranks The Mount Sinai Hospital highly in 11 specialties in “World’s Best Specialized Hospitals,” and in “America’s Best Physical Rehabilitation Centers.”

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

[ad_2]

Health Information Associates, a leading medical coding and auditing company, announces multiple promotions amidst continued growth

[ad_1]

Health Information Associates is the leading medical coding support and auditing company.

Health Information Associates is the leading medical coding support and auditing company.

“The experience, knowledge, and most importantly, leadership of our team is why we are the most well-respected coding and review company in the industry,” says Betsy Bailey, President and Founder of HIA.

Health Information Associates (HIA) is proud to announce multiple leadership promotions across its business development, operations, marketing and technology teams as the company continues significant expansion of its medical coding and auditing services, built across three decades.

The promotions speak to HIAs philosophy of experience, expertise and education by having the most elite subject matter experts in its leadership and decision-making teams.

“HIA has always had a goal of promoting from within whenever possible. We are happy to announce the internal promotions of several key people within our organization,” says Betsy Bailey, President and Founder of HIA. “Many of these individuals have been with HIA for more than 20 years and have been instrumental in the growth and success of our company. The experience, knowledge, and most importantly, leadership of our team is why we are the most well-respected coding and review company in the industry.”


  • Angie Christen, RHIA, a 30-year industry veteran and most recently, Vice President of Operations at HIA, has been promoted to Executive Vice President. Christen joined HIA in 1996, leveraging her experience as a Director of Medical Records and Quality Assurance (QA) to lead HIA in growing its coding support services. In this role, she will continue to oversee all coding operations, recruitment efforts, business operations and technology innovation strategies.
  • Joel Shealy, who joined HIA in 1997, has also been named Executive Vice President after serving in his previous role as Vice President of Business Development. Shealy, a 30-year industry veteran, leverages his business management and marketing background to oversee strategic initiatives, new service line implementation and integrated marketing and sales strategy.
  • Brett Randolph, RHIT, CDIP, CCS, AHIMA Approved ICD-10/PCS Trainer, has been named Vice President of Client Services, promoting him from his previous role as the Executive Director of Review Services. During his 30 years of Health Information Management (HIM) experience, Randolph has worked at every level of the HIM Department including extensive experience in the coding area as a Coder, Coding Manager and Director. He is active in his local American Health Information Management Association (AHIMA) chapter, having served as Director, President and Past President. He is a nationally recognized speaker for AHIMA and AAPC and was also the 2017-2018 recipient of the WVHIMA Distinguished Member award.
  • Daniel Day has been named Vice President of Technology, having been with HIA for nearly 20 years guiding their internal Information Technology systems. Day has led his team in developing HIAs Service-as-a-Software (SaaS), Atom Audit, to be one of the industry’s leading medical coding audit platforms, while continuing to strengthen HIA’s internal operations and security posture.
  • Jean Franza, RHIT, has been named Vice President of Finance. Franza has overseen all of HIAs accounting operations since she joined the company in 2002. Prior to joining HIA, she was a business analyst with Liz Claiborne for 20 years, providing sales data to assist in planning for future lines.
  • Drew Crawford, a 23-year industry veteran, has been promoted to Executive Director of Business Development. Crawford has worked in healthcare-related sales, account management and contracting his entire career. Having spent 20 years with HIA, his in-depth knowledge of HIA’s service capabilities allows him to provide meaningful solutions to clients’ challenges.
  • Beth Ann Moran, MSHIM, has been promoted to Director of Strategic Initiatives. Since she joined HIA in 2015, Moran has worked in both the recruiting and marketing departments. Moran’s new position will spearhead HIA’s effort to expand and enhance its service offerings.
  • Taylor Hankinson has been named Director of Marketing after six years with the company as its Marketing Communications Manager. Hankinson has 15 years of digital marketing experience and has used her knowledge to successfully increase HIAs digital audience, brand visibility, and lead generation through paid, owned and earned media strategies.

About HIA

For the past 30 years, HIA has been the leading provider of compliance audits, coding support services and clinical documentation audit services for hospitals, ambulatory surgery centers, physician groups and other healthcare entities. HIA offers PRN support as well as total outsource support. Most recently, HIA launched Atom Audit, its new medical coding audit and data analytics software. Atom Audit is an easy-to-use, intuitive coding review application that enables auditors to manage the entire audit life cycle efficiently and effectively. Features such as the customizable reporting dashboard and coder workflow give users the ability to turn audit insights into actionable next steps. For more information, visit HIAcode.com or call 866-HIA-CODE.

Share article on social media or email:

[ad_2]

Negative Ice Presents The Wellness Hour A Doctor-Led Discussion at SHOWFIELDS Miami

[ad_1]

“We’re looking forward to an educational and interactive discussion,” said Dr. Brian Weiner, MD, MS, FACP, AGAF, Clinical Associate Professor, Florida Atlantic University Schmidt College of Medicine, former Director of Nutrition, Cleveland Clinic Florida, Weston.

Negative Ice, by the makers of FrutaPOP announced today they will be hosting The Wellness Hour, a doctor-led discussion that will take place at Showfields Miami on November 17th from 5pm – 7pm.

Guests will have the opportunity to listen to a discussion of leading doctors discuss nutrition, gut health, the difference between prebiotics and probiotics, vitamins and other health and wellness topics. There will also be an opportunity to ask questions after the panel.

“We’re looking forward to an educational and interactive discussion,” said Dr. Brian Weiner, MD, MS, FACP, AGAF, Clinical Associate Professor, Florida Atlantic University Schmidt College of Medicine, former Director of Nutrition, Cleveland Clinic Florida, Weston.

Guests will also have the opportunity to enjoy the world’s first and only negative calorie replacement snack, naturally formulated with prebiotics and immune boosting ingredients.

Negative Ice is the first of its kind, a negative calorie replacement snack, -15- calorie ice pop, made with natural ingredients and colors – without any added sugars, syrups or dyes. Each ice pop is backed by science and contains healthy ingredients while also helping you to lose weight. Negative Ice is available in two flavors: Lemon Lime and Mango. Forevery Negative Ice POP consumed, 15 calories are subtracted from your daily caloric intake. Negative Ice helps to burn more calories than are consumed.

Negative Ice will be available for purchase at SHOWFIELDS Miami starting November 17th. For more information, please visit http://www.frutapop.com and follow along on social media @negativeicepop #negativityhasnogain

SHOWFIELDS Miami is located at 530 Lincoln Road, Miami Beach, FL.

Attendance is free and open to the public. Attendees will also receive a gift bag. To RSVP, please visit: https://www.eventbrite.com/e/the-wellness-hour-tickets-460041014057

About NEGATIVE ICE

Negative Ice is the first of its kind, a negative calorie snack replacement, launching with a -15-calorie ice pop, made with natural ingredients and colors – without any added sugars, syrups or dyes. With prebiotics and immune boosting ingredients, each ice pop is backed by science and contains healthy ingredients while also helping you to lose weight. For every Negative Ice POP consumed, 15 calories are subtracted from your daily caloric intake. Negative Ice helps to burn more calories than are consumed.

ABOUT FRUTAPOP

FrutaPOP, the makers of the world’s finest gourmet, alcohol-infused ice pop is reinventing the ice pop – a product that hasn’t seen an innovation in the last 70 years. FrutaPOP is the first of its kind to contain healthy, natural ingredients without any added sugars, syrups or dyes. FrutaPOP created an entirely new product category in the food and beverage industry by offering consumers gourmet, alcohol-infused ice pops, under 5% ABV (alcohol by volume).

###

Share article on social media or email:

[ad_2]

Americans Overwhelmingly Support Auto Technology that Stops Drunk Drivers, New Ipsos Survey Shows

[ad_1]

The cost of inaction is unacceptable, which is why the NTSB continues to push for alcohol impairment detection systems in all new vehicles, among other lifesaving measures.

A new Ipsos poll shows that 9 out of 10 Americans support technology that is integrated into a car’s electronics to prevent drunk driving. The new poll results come one year after the bipartisan HALT Act was signed into law as part of the Infrastructure Investment and Jobs Act. The law gave the National Highway Traffic Safety Administration (NHTSA) three years to establish an auto safety standard for all new cars that detects and prevents impaired driving.

91% of respondents said the technology is a good or very good idea. Support for the technology spans gender, age, income and regional differences. The most common factor that influences support for impaired driving prevention technology in all new cars is cost, according to the poll commissioned by Mothers Against Drunk Driving (MADD). 78% of respondents said they are much more or somewhat more likely to support the technology if it comes at no extra cost to consumers.

“MADD agrees that safety should not just be a luxury for people who can afford to pay for it,” said MADD National President Alex Otte. “Advanced, passive technology that prevents impaired driving should be as standard as seatbelts and airbags – not an upcharge and not an option. There’s a crisis on our roads, and every month we wait to get this technology on all new cars means more than 1,000 preventable deaths and 25,000 preventable injuries caused by drunk driving.”

The bipartisan HALT Act, led by Congresswoman Debbie Dingell in the U.S. House of Representatives and Senator Ben Ray Luján in the U.S. Senate, sets the three-year timeframe for NHTSA to identify the new auto safety standard, then gives auto makers another two to three years to implement it. The three-year timeline began on November 15, 2021. Victims and survivors of impaired driving were the driving force behind the legislation, with strong support from MADD, traffic safety partners, leading alcohol companies and 13 top insurance companies.

“We have the technology now to stop drunk driving, and every day we fail to implement it, more lives are lost to preventable tragedy,” said Congresswoman Dingell. “I’m proud that a year ago, we passed this critical priority as a part of the Bipartisan Infrastructure Law. It is beyond time we made sure it is implemented in vehicles and start saving lives.”

According to the Ipsos poll, 82% of respondents support or somewhat support the Congressional mandate for drunk driving prevention technology in all new cars, up from 77% before the law passed last year.

“Today, I’m honored to mark one year since the HALT/RIDE Act was signed into law, paving the way for safer roads and streets in New Mexico and across our country. As a survivor of a drunk driving crash, I’m proud this initiative will save lives each year and prevent families from receiving that painful phone call of losing a loved one,” said Senator Luján. “As we celebrate this anniversary and the progress we’ve made, we will continue our momentum and work with Secretary Buttigieg and NHTSA to fully implement this law so that no more families know the pain of losing a loved one to drunk or impaired driving.”

In the one year since the HALT Act was signed into law, an independent Technical Working Group was formed to explore potential technologies that could meet the law’s requirement. The Technical Working Group is co-chaired by Stephanie Manning, Chief Government Affairs Officer at MADD, and Dr. Jeffrey Michael, Distinguished Scholar at the Johns Hopkins Center for Injury Research and Policy and former Associate Administrator at NHTSA.

The push for the new auto safety standard received a powerful endorsement in September, when the National Transportation Safety Board (NTSB) issued a strong statement of support for in-vehicle alcohol-detection technology and exploration of other technologies such as driver monitoring. According to the Ipsos poll, 58% of respondents said they were more likely to support passive drunk driving prevention technology in all new cars if the NTSB endorsed it.

“It’s no mystery: we know how to eliminate impaired driving and save thousands of lives every year. What we lack is the will to implement proven solutions,” said NTSB Chair Jennifer Homendy. “The cost of inaction is unacceptable, which is why the NTSB continues to push for alcohol impairment detection systems in all new vehicles, among other lifesaving measures.”

Every 45 minutes in the U.S., a person dies in a drunk driving crash and every 2 minutes a person is injured. MADD has launched a landing page on madd.org with a countdown until the impaired driving prevention standard deadline is met.

The campaign calls attention to thousands of preventable deaths and injuries from alcohol-related crashes since November 15, 2021: the day President Biden signed the historic legislation into law. MADD is urging the public to visit the website and follow simple instructions to ask their U.S. Senators and Representatives to ensure USDOT meets the three-year deadline mandated by the law.

According to the highly respected Insurance Institute for Highway Safety, more than 9,400 deaths could be prevented annually by making impaired driving prevention technology standard in every new car. Countless injuries could also be prevented.

While America’s seven consecutive quarters of traffic fatality increases appeared to reverse course in the second quarter of this year, according to data from NHTSA, the big picture remains unacceptable: Traffic fatalities are still dramatically higher than they were a decade ago. As U.S. Transportation Secretary Pete Buttigieg has stated, we are facing “a national crisis of fatalities and serious injuries.”

About the Ipsos Survey

The poll was conducted October 28-30, 2022, by Ipsos using its KnowledgePanel®. This poll is based on a nationally representative probability sample of 1,030 general population adults age 18 or older, with a margin of sampling error of +/- 3.1 percentage points at the 95% confidence level.

About Mothers Against Drunk Driving

Founded in 1980 by a mother whose daughter was killed by a drunk driver, Mothers Against Drunk Driving® (MADD) is the nation’s largest nonprofit working to end drunk driving, help fight drugged driving, support the victims of these violent crimes and prevent underage drinking. MADD has helped to save more than 400,000 lives, reduce drunk driving deaths by more than 50% and promote designating a non-drinking driver. MADD’s Campaign to Eliminate Drunk Driving® calls for law enforcement support, ignition interlocks for all offenders and advanced vehicle technology. MADD has provided supportive services to nearly one million drunk and drugged driving victims and survivors at no charge through local victim advocates and the 24-Hour Victim Help Line 1-877-MADD-HELP. Visit http://www.madd.org or call 1-877-ASK-MADD.

Share article on social media or email:

[ad_2]

Boulder iQ Names New-Product Specialist Michael Olichney Lead Engineer

[ad_1]

Boulder iQ is an expert contract firm that provides life sciences companies all the services they need to bring products to market quickly and efficiently: regulatory affairs, quality assurance, design, engineering and manufacturing, and sterilization.

Boulder iQ

Mike Olichney’s strong engineering, supervisory and mentoring skills will work to speed new-product development for Boulder iQ’s medical-device clients.

Boulder iQ has named Michael Olichney lead engineer.

Olichney comes to Boulder iQ with more than 35 years of medical device engineering experience, primarily focused on new-product development. Boulder iQ provides design engineering, development and turnkey manufacturing for consumer, high-technology and medical products, and regulatory, clinical and quality management system services for the medical device and in-vitro diagnostic industries.

The engineering leader’s expertise includes mechanical and disposables design, materials selection, fluids modeling, sensitivity analysis and statistical methods. He is proficient in designing test, and verification and validation, programs, and is well-versed in FDA regulatory issues and programs. Olichney has served as inventor on more than 15 U.S. patents.

Before joining Boulder iQ, Olichney was principal engineer and owner of BOCS LLC (Castle Rock, Colorado), a contract and consulting services firm for medical product design and development. Other positions have included: principal engineer at ConMed Advanced Surgical, Team Medical, LLC, Battelle Medical Products/Larren Corporation and RELA Inc.; engineering specialist at Baxter Healthcare; and project engineer, mechanical engineer and project manager at Valleylab Inc. All of his work has been in the Denver-Boulder metro area.

Olichney holds a Bachelor of Science in Mechanical Engineering degree from Rice University.

“Mike brings a critical mass of medical device experience to Boulder iQ,” says Jim Kasic, chairman and founder of Boulder iQ and its Boulder Sterilization Services division. “His strong supervisory and mentoring skills will complement his project management and technical expertise in leading a progressive engineering team, and in speeding new-product development for our clients.”

Boulder iQ (http://www.boulderiq.com)

Boulder iQ is an expert contract firm that provides life sciences companies all the services they need to bring products to market. With specialties in regulatory affairs, quality assurance, design, engineering and manufacturing, the company’s single-source program speeds product development. The Boulder Sterilization Services division, providing quick-turn ethylene oxide sterilization, final assembly and packaging services, is the recent recipient of a $250,000 grant from the Colorado Office of Economic Development and International Trade’s Advanced Industries Accelerator Grant Program.

Based in Boulder, Colorado, Boulder iQ is ISO 13485:2016 certified through Boulder BioMed. The company’s Boulder Medical Device Accelerator provides equity investment in start-up companies seeking product development services, expert mentoring and infrastructure support.

Share article on social media or email:

[ad_2]

Smile Doctors Chooses CureMint to Fuel Procurement Operations for its 350+ Locations

[ad_1]

We selected CureMint’s procure-to-pay platform as we felt it was the best solution to support the 350+ orthodontic practices in our network as well as a process that further empowers our procurement and A/P teams to make intelligent business decisions.

CureMint announced today a new partnership with the largest ortho-focused dental support organization (OSO) in the U.S, Smile Doctors. Smile Doctors selected CureMint’s cost management solution based on its ability to optimize operations between Smile Doctors support and field teams, as well as expand the visibility and efficiency between the organization’s procurement and accounts payable teams.

Smile Doctors provides support to its fast-growing network of orthodontists by providing tools and technology that allow their orthodontists to focus entirely on patient care. It was founded on the principle of creating confident smiles that inspire the best in their patients, each other and the communities they serve. Partnering with a solution like CureMint has enabled their organization to further develop their superior infrastructure by implementing best-in-class processes to support their offices and staff.

“Supporting our team to operate more efficiently with visibility across our supply chain provides us immense value,” said Jim Lebs, CFO at Smile Doctors. “Before CureMint, we were unable to maximize the full potential of our supply chain due to inefficient, manual-heavy workflows which influenced us to search for a tool that better aligned with our business strategy. After evaluating the available options in the market, we selected CureMint’s procure-to-pay platform as we felt it was the best solution to support the 350+ orthodontic practices in our network as well as a process that further empowers our procurement and A/P teams to make intelligent business decisions.”

CureMint’s all-in-one procurement platform empowers dental organizations of all sizes to realize streamlined operations and untapped profitability by removing paper processing while centralizing sourcing, procurement, and accounts payable into one easy-to-use system.

“We understand that the ultimate goal for dental organizations is to provide a great experience and excellent care for their patients and their communities, not to order and pay for things,” said Brandon McCarty, Co-Founder & CEO, CureMint. “We are proud that Smile Doctors has chosen CureMint to not only support them in the execution of their spend and procurement strategy but just as importantly, that they have trusted us to remove the monotonous toll and burden that the day-to-day procurement process has on its tremendous staff.”

About Smile Doctors, LLC

Smile Doctors, LLC, is the largest ortho-focused dental support organization (OSO) in the U.S. The organization has the fastest-growing network of leading orthodontists. With more than 350 convenient locations in 27 states, Smile Doctors has a rich history of developing and growing affiliated practices by providing tools and technology that allow their orthodontists to focus entirely on patient care. Smile Doctors is the largest network of Diamond Plus Invisalign® providers. Smile Doctors orthodontists are proud members of the American Association of Orthodontists, and American Dental Association, and host for the Lecture Center for Orthodontic Excellence. Smile Doctors’ mission is to create confident smiles that inspire the best in their patients, each other, and the communities they serve. For more information, please visit: http://www.smiledoctors.com.

About CureMint

Founded in 2017, CureMint is the leading dental procurement software helping dental organizations scale across North America. CureMint’s B2B SaaS platform helps dental organizations lower costs by bringing greater visibility, control, and efficiency to their internal supply chain. Today, CureMint’s all-in-one platform specifically built for dental practices and DSOs provides an intuitive ordering experience, increased operational efficiency, and holistic spend management for thousands of dental offices across the country. To learn more, visit http://www.curemint.io.

Share article on social media or email:

[ad_2]

Using Point of Care Testing to Transform Patient Care in General Practice and Primary Care Networks, Upcoming Webinar Hosted by Xtalks

[ad_1]

With the National Health Service (NHS) committing to a target of becoming net zero by 2045³, the speakers will explore how the implementation of point of care testing within primary care can assist in reaching this goal.

Patients are experiencing difficulties accessing urgent care, creating a direct impact on GP’s and their ability to facilitate continuity of care to patients who need it. To add to this pressure, primary care teams are finding themselves increasingly stretched beyond capacity¹. Could point of care testing help transform patient care?

Featured speaker Dr. Mayur Lakhani, a practising GP Principal-Partner in Leicestershire and Former President of the Royal College of Practitioners, will discuss how implementing new models of care in general practice and PCNs (Primary Care Networks) using the LumiraDx Platform can assist in tackling the challenges faced within primary care, along with the benefits it could provide for patients and staff.

Dr. Lakhani will also examine the implementation of point of care testing in PCNs in the context of the Fuller Stocktake report¹, and how its adoption can assist in providing more integrated services in system, place and neighbourhood settings. With the introduction of PCNs, the Additional Roles Reimbursement Scheme (ARRS) includes funding for 26,000 essential roles to support PCNs in delivering more personalised and integrated health and social care². The featured speakers will look at how the introduction of point of care testing could assist these roles in bringing change and improvements to patient care pathways. With the National Health Service (NHS) committing to a target of becoming net zero by 2045³, the speakers will explore how the implementation of point of care testing within primary care can assist in reaching this goal.

Join Dr. Mayur Lakhani CBE, GP Partner and ICB Board Member; and Lucy Lehane, Associate Director Medical Affairs, LumiraDx, for the live webinar on Friday, November 25, 2022, at 7am EST (11am GMT-UK/ 12pm CET/EU-Central).

For more information, or to register for this event, visit Using Point of Care Testing to Transform Patient Care in General Practice and Primary Care Networks.

References:

1. Fuller, C. (2022) Next Steps For Integrating Primary Care: Fuller Stocktake Report, NHS choices. NHS. Available at: https://www.england.nhs.uk/publication/next-steps-for-integrating-primary-care-fuller-stocktake-report/ (Accessed: October 24, 2022).

2. Expanding our workforce (no date) NHS choices. NHS England. Available at: https://www.england.nhs.uk/gp/expanding-our-workforce/ (Accessed: October 24, 2022).

3. Delivering a ‘Net Zero’ National Health Service (2020) NHS choices. NHS England and NHS Improvement. Available at: https://www.england.nhs.uk/greenernhs/ (Accessed: October 24, 2022).

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

[ad_2]

AAOMS Recognizes U.S. Oral Surgery Management for Contributing to OMS Specialty

[ad_1]

USOSM President and CEO Richard Hall (R) accepts the Platinum Level award from AAOMS President J. David Johnson Jr. (L).

AAOMS provides a vital service to individual oral and maxillofacial surgeons and to the OMS profession, as a whole. We’re honored to help support them.

U.S. Oral Surgery Management (USOSM) was recently recognized for supporting the oral and maxillofacial surgery (OMS) specialty at the 104th Annual Meeting of the American Association of Oral and Maxillofacial Surgeons (AAOMS), which was held in New Orleans. USOSM President and CEO Richard Hall accepted the award onstage, during AAOMS’s Opening Ceremony, Awards Presentation and Meeting Dedication. AAOMS honored USOSM as one of its Platinum Level corporate supporters for having contributed between $50,000 to $100,000 in support of AAOMS and the OMS Foundation.

“Without the generosity of our corporate and OMS Foundation supporters, many of the educational sessions, activities and special events at the AAOMS Annual Meeting would not be possible,” said J. David Johnson Jr., DDS, the 2021-22 AAOMS President. “We recognize and thank U.S. Oral Surgery Management and all of our other corporate and Foundation supporters for their commitment to AAOMS and our amazing specialty.”

Platinum Level corporate supporters also received special lapel pins to help signal them as champions of the OMS profession throughout the year.

“AAOMS works hard to advance the OMS specialty to ensure oral and maxillofacial surgeons have access to the training, continuing education, research, and support needed to provide patients with the safest and most effective care possible,” said Hall. “AAOMS provides a vital service to individual oral and maxillofacial surgeons and to the OMS profession, as a whole. We’re honored to help support them.”

AAOMS is a not-for-profit, professional association representing more than 11,000 oral and maxillofacial surgeons, OMS residents and professional, allied staff throughout the United States. It has served the professional and public needs of the specialty since 1918. In pursuit of the association’s mission to advance, promote, and preserve oral and maxillofacial surgery, AAOMS appreciates the support provided by companies such as USOSM that share its vision of a technologically advanced specialty to assure patient access to safe and effective care. For more information, visit https://www.aaoms.org/.

Headquartered in Irving, Texas, USOSM has partner practices spanning 21 states. They include Texas, Colorado, Georgia, Tennessee, Minnesota, Alabama, Oklahoma, Louisiana, South Carolina, Mississippi, Florida, Indiana, Kentucky, Arizona, California, Oregon, Virginia, Washington, Massachusetts, Michigan, and Illinois. A shared services organization, USOSM collaborates with premier oral and maxillofacial surgeons to offer a partnership solution for continued and accelerated practice success. USOSM provides operational, marketing and administrative support services, reinvests resources, and applies best practices to improve clinical and financial performance and produce steadier, more profitable growth for all. For more information, visit https://www.usosm.com/.

Share article on social media or email:

[ad_2]